← SynDRA
OXIGLUTATIONE
SynDRA canonical compound SYN0005798 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | GSR | GSTM2 | MGST1 |
|---|
| Mechanism of action | glutathione reductase (nadph) activators |
|---|
| Indication | ocular hypertension |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- GSR OTHER
- Glutathione reductase other
- glutathione reductase (nadph) activators
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ERBB2
- MMP1
- MC5R
- MC4R
- MC3R
- MAPT
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HRH2
- HRH1
- HMGCR
- FYN
- FLT1
- ESR2
- MMP9
- ABCC1
- NPY2R
- PTPRC
- TDP1
- TBXAS1
- TACR2
- TACR1
- SLC6A4
- SLC6A3
- SLC6A2
- SLC17A5
- SIGMAR1
- PTGS2
- NR3C1
- PTGS1
- PTAFR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- BSS PLUS
- METHOTREXATE SODIUM
- NAVSTEL
- glutathione disulfide
- glutathione disulphide
- Glutathione disulfide
- Oxiglutationa
- Oxiglutatione component of navstel
- Glutathione Disulfide
- GSSG
- Glutathione disulphide
- Oxigluthione
- Glutathone disulfide
- Oxiglutationum
- Bis(gamma-glutamyl-L-cysteinylglycine) disulfide
- ULW86O013H
- Disulfide, Glutathione
- RefChem:57055
- Glutathione-ssg
- Oxiglutatione [INN]
- Bi(glutathion-S-yl)
- Oxiglutationum [INN-Latin]
- Oxiglutationa [INN-Spanish]
- CCRIS 780
- Glutathione oxidized form
- MFCD00063106
- glutathione ox
- C20H32N6O12S2
- L(-)-Glutathione
- GDS
- EINECS 248-170-7
- Glutathione-S-S-glutathione
- UNII-ULW86O013H
- Navstel
- ox. glutathione
- NCGC00164484-02
- oxidised glutathione
- Sleep-promoting factor B
Look up OXIGLUTATIONE in the interactive SynDRA portal →